Literature DB >> 12354109

Proteasome-driven turnover of tryptophan hydroxylase is triggered by phosphorylation in RBL2H3 cells, a serotonin producing mast cell line.

Yoshiko Iida1, Keiko Sawabe, Masayo Kojima, Kazuya Oguro, Nobuo Nakanishi, Hiroyuki Hasegawa.   

Abstract

We previously demonstrated in mast cell lines RBL2H3 and FMA3 that tryptophan hydroxylase (TPH) undergoes very fast turnover driven by 26S-proteasomes [Kojima, M., Oguro, K., Sawabe, K., Iida, Y., Ikeda, R., Yamashita, A., Nakanishi, N. & Hasegawa, H. (2000) J. Biochem (Tokyo) 2000, 127, 121-127]. In the present study, we have examined an involvement of TPH phosphorylation in the rapid turnover, using non-neural TPH. The proteasome-driven degradation of TPH in living cells was accelerated by okadaic acid, a protein phosphatase inhibitor. Incorporation of 32P into a 53-kDa protein, which was judged to be TPH based on autoradiography and Western blot analysis using anti-TPH serum and purified TPH as the size marker, was observed in FMA3 cells only in the presence of both okadaic acid and MG132, inhibitors of protein phosphatase and proteasome, respectively. In a cell-free proteasome system constituted mainly of RBL2H3 cell extracts, degradation of exogenous TPH isolated from mastocytoma P-815 cells was inhibited by protein kinase inhibitors KN-62 and K252a but not by H89. Consistent with the inhibitor specificity, the same TPH was phosphorylated by exogenous Ca2+/calmodulin-dependent protein kinase II in the presence of Ca2+ and calmodulin but not by protein kinase A (catalytic subunit). TPH protein thus phosphorylated by Ca2+/calmodulin-dependent protein kinase II was digested more rapidly in the cell-free proteasome system than was the nonphosphorylated enzyme. These results indicated that the phosphorylation of TPH was a prerequisite for proteasome-driven TPH degradation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354109     DOI: 10.1046/j.1432-1033.2002.03188.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Disrupted placental serotonin synthetic pathway and increased placental serotonin: Potential implications in the pathogenesis of human fetal growth restriction.

Authors:  Suveena Ranzil; Stacey Ellery; David W Walker; Cathy Vaillancourt; Nadia Alfaidy; Alexander Bonnin; Anthony Borg; Euan M Wallace; Peter R Ebeling; Jan Jaap Erwich; Padma Murthi
Journal:  Placenta       Date:  2019-05-23       Impact factor: 3.481

Review 2.  Melatonin and ubiquitin: what's the connection?

Authors:  Jerry Vriend; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-06-12       Impact factor: 9.261

3.  Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension.

Authors:  Ian Morecroft; Katie White; Paola Caruso; Margaret Nilsen; Lynn Loughlin; Raul Alba; Paul N Reynolds; Sergei M Danilov; Andrew H Baker; Margaret R Maclean
Journal:  Mol Ther       Date:  2012-04-24       Impact factor: 11.454

Review 4.  Developmental role of tryptophan hydroxylase in the nervous system.

Authors:  Kazuhiro Nakamura; Hiroyuki Hasegawa
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.682

5.  Production and Peripheral Roles of 5-HTP, a Precursor of Serotonin.

Authors:  Kazuhiro Nakamura; Hiroyuki Hasegawa
Journal:  Int J Tryptophan Res       Date:  2009-03-30

6.  Posttranscriptional regulation of adrenal TH gene expression contributes to the maladaptive responses triggered by insulin-induced recurrent hypoglycemia.

Authors:  Necla Kudrick; Owen Chan; Edmund F La Gamma; Juhye Lena Kim; Arnold William Tank; Carol Sterling; Bistra B Nankova
Journal:  Physiol Rep       Date:  2015-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.